HomeCompareNNLRF vs SBUX

NNLRF vs SBUX: Dividend Comparison 2026

NNLRF yields 476.19% · SBUX yields 2.75%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NNLRF wins by $42190.58M in total portfolio value
10 years
NNLRF
NNLRF
● Live price
476.19%
Share price
$0.42
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$42190.73M
Annual income
$29,856,826,336.61
Full NNLRF calculator →
SBUX
SBUX
● Live price
2.75%
Share price
$89.59
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$157.5K
Annual income
$65,840.13
Full SBUX calculator →

Portfolio growth — NNLRF vs SBUX

📍 NNLRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNNLRFSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NNLRF + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NNLRF pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NNLRF
Annual income on $10K today (after 15% tax)
$40,476.19/yr
After 10yr DRIP, annual income (after tax)
$25,378,302,386.12/yr
SBUX
Annual income on $10K today (after 15% tax)
$233.40/yr
After 10yr DRIP, annual income (after tax)
$55,964.11/yr
At 15% tax rate, NNLRF beats the other by $25,378,246,422.01/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NNLRF + SBUX for your $10,000?

NNLRF: 50%SBUX: 50%
100% SBUX50/50100% NNLRF
Portfolio after 10yr
$21095.45M
Annual income
$14,928,446,088.36/yr
Blended yield
70.77%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

NNLRF
No analyst data
Altman Z
1.2
Piotroski
2/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+16.1% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NNLRF buys
0
SBUX buys
0
No recent congressional trades found for NNLRF or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNNLRFSBUX
Forward yield476.19%2.75%
Annual dividend / share$2.00$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%48.3%
Portfolio after 10y$42190.73M$157.5K
Annual income after 10y$29,856,826,336.61$65,840.13
Total dividends collected$41105.99M$127.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: NNLRF vs SBUX ($10,000, DRIP)

YearNNLRF PortfolioNNLRF Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$58,319$47,619.05$11,107$407.21+$47.2KNNLRF
2$321,943$259,541.82$12,512$626.87+$309.4KNNLRF
3$1,683,516$1,339,036.49$14,366$978.69+$1.67MNNLRF
4$8,345,411$6,544,049.07$16,929$1,557.50+$8.33MNNLRF
5$39,247,085$30,317,495.29$20,658$2,543.80+$39.23MNNLRF
6$175,244,996$133,250,614.99$26,406$4,302.22+$175.22MNNLRF
7$743,574,718$556,062,572.68$35,877$7,622.00+$743.54MNNLRF
8$3,000,677,157$2,205,052,208.89$52,741$14,352.64+$3000.62MNNLRF
9$11,527,017,061$8,316,292,502.31$85,676$29,243.03+$11526.93MNNLRF
10$42,190,734,592$29,856,826,336.61$157,513$65,840.13+$42190.58MNNLRF

NNLRF vs SBUX: Complete Analysis 2026

NNLRFStock

The REIT was formed to acquire specialized industrial and retail properties leased to experienced, top-tier, creditworthy state-licensed operators for their Regulated Cannabis facilities ("Licensed Facilities") in the United States. The REIT intends to acquire properties through sale-leaseback transactions and lease such properties on a triple net lease basis for a targeted 10 to 15 year term and strives to negotiate annual rental rate increases in the leases. The REIT's portfolio will consist of only Licensed Facilities in the United States with a targeted mix of 80% cultivation/grow/processing facilities and 20% retail/dispensary. The REIT is internally managed by a vertically integrated team of seasoned real estate and cannabis professionals with expertise across the spectrum of real estate investment management, including: acquisitions, underwriting, financing, asset management, property management, operations, development and redevelopment, accounting and regulatory affairs.

Full NNLRF Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this NNLRF vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NNLRF vs SCHDNNLRF vs JEPINNLRF vs ONNLRF vs KONNLRF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.